Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-081720·KIDRON NADAV
Schedule 13D ownership disclosure
Oramed Pharmaceuticals, Inc.
Common Stock par value $0.012 per share · CUSIP: 68403P203
Event date: 2025-02-11
- Filing-level shares
- 3,116,729.00
- Percent of class
- 7.6%
- Nadav KidronReported CIK 0001351779
Shares: 3,116,729.00 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-081720
- Form type
- SCHEDULE 13D/A
- Filer
- KIDRON NADAV
- CIK
- CIK 1351779
- Filed
- Aug 28, 2025
- Reporting period
- Feb 11, 2025
- Description
- Schedule 13D beneficial ownership